- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 95.1M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 105.07M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $174.44M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $182.83M |
| Capex | Q1 2026 · Mar 31, 2026 | $391K |
| Capex | Q1 2026 · Mar 31, 2025 | $2.24M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $69.85M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $67.88M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $0 |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $0 |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $72.05M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $190.52M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $237.13M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $374.2M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $402.05M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $541.69M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $97.95M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $100.54M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $282.49M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $287.7M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $161.87M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $282.95M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $519.61M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $661.9M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.34 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.37 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.34 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.38 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $26.48M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $24.79M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $37.67M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $35.03M |
| Net Income | Q1 2026 · Mar 31, 2026 | $32.23M |
| Net Income | Q1 2026 · Mar 31, 2025 | $39.05M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $40.08M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $50.65M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $224.62M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $197.89M |
| Revenue | Q1 2026 · Mar 31, 2026 | $243.56M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $212.24M |